Found: 32
Select item for more details and to access through your institution.
Immune pressures drive the promoter hypermethylation of neoantigen genes.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Gut microbiome and CAR-T therapy.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0155-8
- By:
- Publication type:
- Article
A high-throughput screening identifies histone deacetylase inhibitors as therapeutic agents against medulloblastoma.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0153-x
- By:
- Publication type:
- Article
Advances and perspectives of PARP inhibitors.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0154-9
- By:
- Publication type:
- Article
Recent advances on blinatumomab for acute lymphoblastic leukemia.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0152-y
- By:
- Publication type:
- Article
Development of molecular and pharmacological switches for chimeric antigen receptor T cells.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysis.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0150-0
- By:
- Publication type:
- Article
Targeted and novel therapy in advanced gastric cancer.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0149-6
- By:
- Publication type:
- Article
Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0148-7
- By:
- Publication type:
- Article
LY86, LRG1 and PDE9A genes overexpression in umbilical cord blood hematopoietic stem progenitor cells by acute myeloid leukemia (M3) microvesicles.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Cabozantinib and apixaban: an hitherto unreported interaction.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Role of some members of chemokine/cytokine network in the pathogenesis of thalassemia and sickle cell hemoglobinopathies: a mini review.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0145-x
- By:
- Publication type:
- Article
Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0140-2
- By:
- Publication type:
- Article
Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0138-9
- By:
- Publication type:
- Article
Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0143-z
- By:
- Publication type:
- Article
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH).
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0142-0
- By:
- Publication type:
- Article
Frontline therapies for untreated chronic lymphoid leukemia.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0139-8
- By:
- Publication type:
- Article
Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0141-1
- By:
- Publication type:
- Article
A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0144-y
- By:
- Publication type:
- Article
Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0132-2
- By:
- Publication type:
- Article
An expanded biomarker panel for the detection of prostate cancer from urine DNA.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0137-x
- By:
- Publication type:
- Article
NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0135-z
- By:
- Publication type:
- Article
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0133-1
- By:
- Publication type:
- Article
Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0134-0
- By:
- Publication type:
- Article
Novel GTF2I–PDGFRB and IKZF1–TYW1 fusions in pediatric leukemia with normal karyotype.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0136-y
- By:
- Publication type:
- Article
The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0131-3
- By:
- Publication type:
- Article
Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0125-6
- By:
- Publication type:
- Article
Immunotherapy in extensive small cell lung cancer.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0129-x
- By:
- Publication type:
- Article
Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0128-y
- By:
- Publication type:
- Article
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0127-z
- By:
- Publication type:
- Article
Mantle cell lymphoma and its management: where are we now?
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0126-0
- By:
- Publication type:
- Article
Thyroid dysfunction from inhibitor of fibroblast growth factor receptor.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0130-4
- By:
- Publication type:
- Article